For years, clinical AI was adopted in a straightforward way: find a specific clinical problem, such as detecting a brain bleed on a CT scan, and buy a specialized, FDA-cleared tool to address it. These tools worked well for single procedures, but by 2027, this direct-to-vendor approach will no longer work.
We are seeing a major shift in the market. People are realizing that adding more and more clinical AI solutions to a single study brings limited productivity gains and rising costs. Leading health systems are now moving toward Foundational Models, reusable platforms that can be used for many different tasks.
Take a typical CT Chest study. A radiologist usually checks for more than 20 conditions, such as pulmonary nodules, PE, emphysema, and coronary artery calcification. In the old model, covering all these findings meant using up to a dozen different vendors, which is expensive and hard to manage.
If fully adopted, an average practice could end up using more than 100 AI models just in radiology. This could actually quadruple the amount of data a radiologist sees for each patient, making their job harder instead of easier.
The key advantage in 2026 is shifting from single-purpose tools to adaptive, multimodal Foundation Models. This move takes us from just analyzing images to generating full reports, “Pixels to Paragraphs.”
The goal isn’t just "catching a finding," but delivering a comprehensive pre-drafted report. With that goal in mind, GenAI can potentially handle up to 90% of the workload for routine, low-acuity cases, which accounts for 65-70% of total volume, allowing clinicians to focus their expertise on the most complex studies.
But here's what separates real productivity gains from chaos: a platform manages what dozens of point solutions cannot. Without a unified approach, each model lives in its own island. One vendor's output doesn't talk to another's. Workflows break. Clinicians jump between tools. IT teams spend their time stitching together integrations instead of scaling what works. A platform approach changes this.
It collectivizes, standardizes, and organizes all those model outputs into a single clinical workflow. Instead of managing 100 separate integrations, IT maintains one deployment fabric. Instead of 100 separate security reviews, one governance framework covers the entire portfolio. Instead of clinicians hunting through vendor dashboards, they see unified results where they work, in their existing systems, at the moment of care.
This is already happening. Real-world data published in JAMA Network Open (June 2025) shows that generative AI systems built in-house at places like Northwestern Medicine can increase radiologist productivity by up to 40%. In actual clinical care, these systems improved documentation efficiency by 15.5% without affecting clinical accuracy.
To go from a small pilot to a widely used digital tool, senior leaders in health systems need to focus on how these models are deployed and governed.
1.Ensure Local Accuracy: Foundation models work well out of the box, but they need to be adjusted locally to reach a clinical grade that fits your patient population.
2.Standardize the Deployment Fabric: Avoid creating more isolated systems. Invest in a platform that lets you manage over 100 models as easily as managing just one.
3.Keep AI Secure: Enterprise-grade AI should run within your own security boundaries. As Google’s preferred MedGemma deployment partner, Ferrum Health lets you retrain these models on your local data and deploy them securely behind your firewall.
Moving to Foundational Models is the only way to handle growing volumes without burning out clinicians. By switching from many fixed tools to a stable foundational platform, clinical AI becomes more than just a cost; it becomes a lasting source of revenue and safety for the future.